AB-2100

all catalysts(0)

nothing on the calendar yet

News(2)

• ArsenalBio sacrifices ‘majority’ of staff in pivot to in vivo CAR T
  After downsizing by 50% last year, Arsenal Biosciences is again laying off employees. This time, 99 people are getting cut as part of a strategic shift to focus the company’s R&D efforts on in vivo…
  biospace · 1mo ago
• ArsenalBio sheds most of staff in pivot to in vivo CAR-T
  About a year after halving its staff in a clinical push, Arsenal Biosciences is now making a hard pivot that involves laying off most of its employees and seeking out new homes for its assets.
  fiercebiotech · 1mo ago